Clinical Trial Update: Improving Efficacity of Sleeve Gastrectomy With Naltrexone/Bupropion Extended-release Tablet [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial sponsored by Laval University is evaluating whether extended-release naltrexone/bupropion improves outcomes after sleeve gastrectomy in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity
• Obesity

Drugs mentioned

• Naltrexone/bupropion extended-release tablet (naltrexone/bupropion)

Snippet

Sponsor: Laval University | Conditions: Obesity; Drug, Obesity, Morbid | Phase 4 | Status: RECRUITING